Glomerular filtration rate estimation using the Cockcroft-Gault and Modification of Diet in Renal Disease formulas for digoxin dose adjustment in patients with heart failure

References

• Pervaiz MH, Dickinson MG, Yamani M. Is digoxin a drug of the past?. Cleve Clin J Med. 2006; 73: 821–34
   PubMed Web of Science ®Google Scholar
• Bauman JL, DiDomenico RJ, Galanter WL. Mechanisms, manifestations, and Management of digoxin toxicity in the modern era. Am J Cardiovasc Drugs. 2006; 6: 77–86
   PubMedGoogle Scholar
• Olyaei AJ, Demattos AM, Bennet WM. Drug dosage in renal failure. Clinical nephrotoxins: renal injury from drugs and chemicals, ME De Broe, GA Porter, WM Bennet, GA Verpooten. Kluwer Academic, DordrechtThe Netherlands 2003; 667–79
   Google Scholar
• Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007; 75: 1487–96
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31–4
   PubMed Web of Science ®Google Scholar
• Levey AS, Greene T, Kusek JW, Beck GJ. MDRD Study Group. A simplified equation to predict GFR from serum creatinine [abstract]. J Am Soc Nephrol. 2000; 11: 155A
   Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130: 461–70
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354: 2473–83
   PubMed Web of Science ®Google Scholar
• Laroche ML, Charmes JP, Marcheix A, Bouthier F, Merle L. Estimation of glomerular filtration rate in elderly: Cockcroft-Gault formula versus modification of diet in renal disease formula. Pharmacotherapy. 2006; 26: 1041–6
   PubMed Web of Science ®Google Scholar
• Wargo KA, Eiland EH, Hamm W, English TM, Philippe HM. Comparison of modification of diet in renal disease and Cockcroft-Gault equations for antimicrobial dosage adjustments. Ann Pharmacother. 2006; 40: 1248–53
   PubMed Web of Science ®Google Scholar
• Golik MV, Lawrence KR. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and modification of diet in renal disease. Pharmacotherapy. 2008; 28: 1125–32
   PubMed Web of Science ®Google Scholar
• Bookstaver PB, Johnson JW, McCoy TP, Williamson JC. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann Pharmacother. 2008; 42: 1758–65
   PubMed Web of Science ®Google Scholar
• Spruill WJ, Wade WE, Cobb HH. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function. Am J Geriatr Pharmacother. 2008; 6: 153–60
   PubMedGoogle Scholar
• Livio F, Biollaz J, Burnier M. Estimation de la function rénale par l′equation MDRD: intérêt et limites pour l′adaptation des doses de médicaments. Rev Med Suisse. 2008; 181: 2596–600
   Google Scholar
• Roblin I, De Sobarnitsky S, Basselin C, Vial F, Bard E, Dufrene I, et al. Estimated glomerular filtration rate for drug dose adjustment: Cockcroft and Gault or abbreviated MDRD equation?. Clin Biochem. 2009; 42: 111–3
   PubMed Web of Science ®Google Scholar
• Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group—a cautionary tale. Nephrol Dial Transplant. 2007; 22: 2894–9
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. Glomerular filtration rate (GFR) calculator. Available at: www.kidney.org/professionals/kdoqi/gfr_calculator.cfm.
   Google Scholar
• Winter ME. Basic clinical pharmacokinetics4th ed. Lippincot Williams & Wilkins, Philadelphia 2004; 183–221
   Google Scholar
• Eksborg S. Evaluation of method-comparison data. Clin Chem. 1981; 27: 1311–2
   PubMed Web of Science ®Google Scholar
• Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharmacokinet. 1981; 16: 249–55
   Google Scholar
• Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilveray IJ, et al. Bioanalytical method validation. A revisit with a decade of progress. Pharm Res. 2000; 17: 1551–7
   PubMedGoogle Scholar
• O'Riordan S, Ouldred E, Brice S, Jackson SHD, Swift CG. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol. 2002; 53: 398–402
   PubMed Web of Science ®Google Scholar
• Koup JR, Jusko WJ, Elwoood CM, Kohli RK. Digoxin pharmacokinetics: role of renal failure in dosage regimen design. Clin Pharmacol Ther. 1975; 18: 9–21
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Dan Y, Hirata S, Ohtani H, Sawada Y. Influence of SLCO1B3 gene polymorphism on the pharmacokinetics of digoxin in terminal renal failure. Drug Metab Pharmacokinet. 2008; 26: 406–11
   Google Scholar
• Tsujimoto M, Kinoshita Y, Hirata S, Otagiri M, Ohtari H, Sawada Y. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin. Ther Drug Monit. 2008; 30: 576–82
   PubMed Web of Science ®Google Scholar
• Dasgupta A. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances. Toxicol Rev. 2006; 25: 273–81
   PubMedGoogle Scholar
• Bauman JL, DiDomenico RJ, Viana M, Fitch M. A method of determining the dose of digoxin for heart failure in the modern era. Arch Intern Med. 2008; 166: 2539–45
   Google Scholar
• Schentag JJ, Bang AJ, Kozinski-Tober JL. Digoxin. Applied pharmacokinetics and pharmacodynamics. Principles of therapeutic drug monitoring4th ed, ME Burton, LM Shaw, JJ Schentag, WE Evans. Lippincot Williams & Wilkins, Philadelphia 2006; 410–39
   Google Scholar